Accueil / Tag Archives: Hospitals

Tag Archives: Hospitals

Netsmart Continues Post-Acute Expansion with DeVero Acquisition

Wednesday, July 19th 2017 at 12:30pm UTC OVERLAND PARK, Kan.–(BUSINESS WIRE)– Netsmart announced it has acquired DeVero, a healthcare technology company that specializes in home healthcare and hospice. Netsmart is an innovative healthcare technology provider that provides electronic health records (EHRs), health information exchange, data analytics, mobile clinical and consumer …

Plus »

U.S. Food and Drug Administration Approves Gilead’s Vosevi™ (Sofosbuvir/Velpatasvir/Voxilaprevir) for Re-Treatment of Adults with Chronic Hepatitis C Virus

Tuesday, July 18th 2017 at 5:35pm UTC – Vosevi is the First Once-daily Single-Tablet HCV Regimen Approved as Salvage Therapy for Certain Patients and Completes Gilead’s Portfolio of Sofosbuvir-based HCV Direct-acting Antiviral (DAA) Treatments – FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food …

Plus »

$3 Million Investment Establishes the Teresa and Byron Pollitt Family Chair in Fetal and Neonatal Medicine at Children’s Hospital Los Angeles

Tuesday, July 18th 2017 at 9:45pm UTC Endowment supports research priorities to improve outcomes and clinical care for more than 2,000 infants and high-risk pregnant women who depend on CHLA each year LOS ANGELES–(BUSINESS WIRE)– Inspired by a family mantra and a longstanding relationship with both Children’s Hospital Los Angeles …

Plus »

SpinalCyte, LLC Receives New Japanese Patent

Thursday, July 20th 2017 at 6:12pm UTC HOUSTON–(BUSINESS WIRE)– SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the issuance of Japanese Patent No. 6151006, “Methods And Compositions For Repair Of Cartilage Using An In Vivo Bioreactor.” …

Plus »

Clovis Oncology to Announce Second Quarter 2017 Financial Results and Host Webcast Conference Call on August 2

Wednesday, July 19th 2017 at 12:00pm UTC BOULDER, Colo.–(BUSINESS WIRE)– Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2017 financial results on Wednesday, August 2, 2017, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 …

Plus »

Baxter Releases Annual Corporate Responsibility Report; Announces Progress Toward Social and Environmental 2020 Goals

Thursday, July 20th 2017 at 2:00pm UTC Company Also Recognized for the 4th Consecutive Year as One of the 50 Most Community-Minded Companies in the United States by Points of Light DEERFIELD, Ill.–(BUSINESS WIRE)– Baxter International Inc. (NYSE: BAX), a global medical products company, today announced the publication of its …

Plus »

NeuroVia Closes Series A Financing Round of $14M to Develop Novel Treatment Option for X-ALD Disease

Thursday, July 20th 2017 at 11:30am UTC Funds Will Allow NeuroVia to Advance Lead Candidate NV1205 into a Multi-National Clinical Proof of Concept Program CAMBRIDGE, Mass.–(BUSINESS WIRE)– NeuroVia, Inc., a biopharmaceutical company focused on developing innovative therapies for rare genetic neurological diseases, announced the closing of a Series A financing …

Plus »

FUJIFILM Corporation annonce les résultats de l’essai clinique de phase II portant sur le « T-817MA », chez des patients atteints de la maladie d’Alzheimer aux États-Unis

Wednesday, July 19th 2017 at 9:59pm UTC TOKYO–(BUSINESS WIRE)– FUJIFILM Corporation (TOKYO : 4901) (Président : Kenji Sukeno) a annoncé que le médicament « T-817MA » de la société destiné à la maladie d’Alzheimer n’avait pas satisfait aux critères d’évaluation de la cognition ni de la fonction clinique globale de son étude primaire, dans …

Plus »

Baxter Appoints Cathy R. Smith to Its Board

Monday, July 17th 2017 at 8:30pm UTC Target CFO Complements Current Board Expertise DEERFIELD, Ill.–(BUSINESS WIRE)– Baxter International Inc. (NYSE:BAX) today announced it has appointed Cathy R. Smith, executive vice president (EVP) and chief financial officer (CFO), Target Corporation, to its Board of Directors, bringing the total number of directors …

Plus »

Healthcare Analytics News™ Unveils its First Print Edition for July 2017

Wednesday, July 19th 2017 at 1:51pm UTC The premier print issue’s cover story focuses on recent ransomware cyberattacks CRANBURY, N.J.–(BUSINESS WIRE)– Healthcare Analytics News™, a premier media platform that connects healthcare technology professionals and other key stakeholder with an array of valuable resources and the official publication of Healthcare Research …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...